Journal Title：Molecular Imaging And Biology

Molecular Imaging and Biology (MIB) invites original contributions (research articles, review articles, commentaries, etc.) on the utilization of molecular imaging (i.e., nuclear imaging, optical imaging, autoradiography and pathology, MRI, MPI, ultrasound imaging, radiomics/genomics etc.) to investigate questions related to biology and health. The objective of MIB is to provide a forum to the discovery of molecular mechanisms of disease through the use of imaging techniques. We aim to investigate the biological nature of disease in patients and establish new molecular imaging diagnostic and therapy procedures.

Some areas that are covered are:

Preclinical and clinical imaging of macromolecular targets (e.g., genes, receptors, enzymes) involved in significant biological processes.

The design, characterization, and study of new molecular imaging probes and contrast agents for the functional interrogation of macromolecular targets.

Development and evaluation of imaging systems including instrumentation, image reconstruction algorithms, image analysis, and display.

Development of molecular assay approaches leading to quantification of the biological information obtained in molecular imaging.

Study of in vivo animal models of disease for the development of new molecular diagnostics and therapeutics.

Extension of in vitro and in vivo discoveries using disease models, into well designed clinical research investigations.

Clinical molecular imaging involving clinical investigations, clinical trials and medical management or cost-effectiveness studies.

分子成像與生物學 (MIB) 誠邀原創投稿（研究文章、評論文章、評論等），探討如何利用分子成像（即核成像、光學成像、放射自顯影和病理學、MRI、MPI、超聲成像、放射組學/基因組學等）研究生物學和健康相關問題。MIB 的目標是提供一個論壇，通過利用成像技術來發現疾病的分子機制。我們的目標是研究患者疾病的生物學性質，并建立新的分子成像診斷和治療程序。

涵蓋的一些領域包括：

涉及重要生物過程的大分子靶標（例如基因、受體、酶）的臨床前和臨床成像。

設計、表征和研究用于功能性詢問大分子靶標的新型分子成像探針和造影劑。

開發和評估成像系統，包括儀器、圖像重建算法、圖像分析和顯示。

開發分子檢測方法，以量化分子成像中獲得的生物信息。

研究體內疾病動物模型，以開發新的分子診斷和治療方法。

將使用疾病模型的體外和體內發現擴展到精心設計的臨床研究調查中。

涉及臨床研究、臨床試驗和醫療管理的臨床分子成像或成本效益研究。

Molecular Imaging And Biology創刊于2005年，由Springer International Publishing出版商出版，收稿方向涵蓋醫學 - 核醫學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 約3.0個月 ，影響因子指數3，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。